NovaBay Pharmaceuticals, Inc. (NBY) |
|
0.48 -0.005 (-1.03%)
|
09-27 16:00 |
|
Open: |
0.479 |
Pre. Close: |
0.485 |
|
High:
|
0.5068 |
Low:
|
0.4721 |
|
Volume:
|
170,256 |
Market Cap:
|
2(M) |
|
|
|
Technical analysis |
as of: 2023-09-27 4:20:58 PM |
|
Short-term rate:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
|
Mid-term rate:
|
  |
| Target: |
Six months: 1.11 One year: 1.49 |
| Support: |
Support1: 0.41 Support2: 0.34 |
| Resistance: |
Resistance1: 0.95 Resistance2: 1.27 |
| Pivot: |
0.51  |
| Moving Average: |
MA(5): 0.46 MA(20): 0.53
MA(100): 0.68 MA(250): 1.62 |
| MACD: |
MACD(12,26): -0.1 Signal(9): -0.1 |
| Stochastic oscillator: |
%K(14,3): 7.2 %D(3): 6.1 |
| RSI: |
RSI(14): 40.1 |
| 52-week: |
High: 4.55 Low: 0.41 |
| Average Vol(K): |
3-Month: 1,228 (K) 10-Days: 666 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ NBY ] has closed above bottom band by 39.0%. Bollinger Bands are 4.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.51 - 0.51 |
0.51 - 0.51 |
|
Low:
|
0.47 - 0.47 |
0.47 - 0.47 |
|
Close:
|
0.48 - 0.48 |
0.48 - 0.49 |
|
Company Description |
|
NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California. |
Headline News |
Mon, 18 Sep 2023
BioStem Technologies Engages PCG Advisory for Strategic Investor ... - InvestorsObserver
Wed, 13 Sep 2023
Thinking about buying stock in Lyra Therapeutics, Wework ... - PR Newswire
Mon, 11 Sep 2023
Why Avantax Shares Are Trading Higher By Over 27%? Here Are ... - Investing.com UK
Mon, 11 Sep 2023
Is it Time to Dump NovaBay Pharmaceuticals Inc (NBY) Stock After it Has Risen 38.33% in a Week? - InvestorsObserver
Mon, 11 Sep 2023
Pharmaceutical Breakthroughs Transforming Patient Care and ... - Best Stocks
Tue, 15 Aug 2023
NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q2 2023 Earnings Call Transcript - Yahoo Finance
|
Financial Analysis |
| Price to Book Value: |
Neutral |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Neutral |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: AMEX |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. |
0 (M) |
| Shares Float |
0 (M) |
|
% Held by Insiders
|
0 (%) |
|
% Held by Institutions
|
0 (%) |
|
Shares Short
|
0 (K) |
|
Shares Short P.Month
|
0 (K) |
Stock Financials |
|
EPS
|
0 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
0 |
|
Return on Assets (ttm)
|
0 |
|
Return on Equity (ttm)
|
0 |
|
Qtrly Rev. Growth
|
0 |
|
Gross Profit (p.s.)
|
0 |
|
Sales Per Share
|
0 |
|
EBITDA (p.s.)
|
0 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
0 (M) |
Stock Valuations |
|
PE Ratio
|
0 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0 |
|
Price to Sales
|
0 |
|
Price to Cash Flow
|
0 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
